Biotechnology Market Analysis by Application (Health, Food & Agriculture, Natural Resources & Environment, Industrial Processing Bioinformatics), by Technology and Segment Forecasts, 2014 - 2025 - Product Image

Biotechnology Market Analysis by Application (Health, Food & Agriculture, Natural Resources & Environment, Industrial Processing Bioinformatics), by Technology and Segment Forecasts, 2014 - 2025

  • ID: 4396357
  • Report
  • Region: Global
  • 149 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • Abbott
  • AstraZeneca
  • CELGENE CORPORATION
  • Gilead
  • Merck & Co
  • Novo Nordisk A/S
  • MORE
The global biotechnology market is expected to reach USD 727.1 billion by 2025. The emergence of certain key themes in the biotechnology market is expected to drive growth in this industry to a lucrative extent.

These key themes include regenerative medicine and genetics in diagnostics. Presence of a plethora of companies focusing on the development of regenerative therapies is anticipated to drive sector growth through to 2025. Technological advancements pertaining to the penetration of artificial intelligence in this industry is expected to fuel progress with potential avenues. The companies are engaged in unleashing machine learning in order to understand individual cancer cases, while recommending clinical trials.

Supportive government (and its allied agencies) policies related to synthetic biology is a major growth impacting driver in this sector. Developed economies such as UK and the U.S. are critically monitoring and funding synthetic biology R&D initiatives. For example, in 2010, a six months’ review of synthetic biology headed by a panel of expert scientists was enforced by the U.S. President and subsequently conducted a hearing of the Energy and Commerce Committee exclusively concerning synthetic biology.

Further key findings from the report suggest:
  • Owing to technological advancements and widespread application of this field in various aspects of healthcare, the health segment is expected to exhibit strong progress in the forecast period
  • Continuous introduction of new biotechnological products to cater to healthcare entities that are involved in diagnosis, prognosis and biopharmaceutical development is estimated to propel the market
  • Decreasing costs and rise in number of services in this segment are expected to drive segment with lucrative avenues
  • North American pharmaceutical and biotech companies have experienced great success in the recent years resulting in larger share
  • Introduction of technologically advanced products and presence of various biotechnology based programs such as the UC Davis Biotechnology Program, the University of California Biotechnology Research and Education Program are attributive to drive the growth of sector in the coming years
  • Asia Pacific market is anticipated to grow at the most lucrative pace due to changing health care infrastructure in this region which drives the demand for these products
  • Strong governmental support and recruitment of highly trained Chinese scientists with the support of their administration has made it possible for China to speedily build up capacity in area of regenerative medicine
  • Key players operating include Gilead, Celgene, Abbott, Novo Nordisk A/S,Novartis AG, Sanofi Aventis, and Lonza
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • AstraZeneca
  • CELGENE CORPORATION
  • Gilead
  • Merck & Co
  • Novo Nordisk A/S
  • MORE

Chapter 1 Research Methodology
1.1 Information Procurement
1.1.1 Purchased Database
1.1.2 Internal database
1.2 Data Analysis
1.3 Market Formulation & Validation
1.4 Approaches for Market Estimation
1.4.1 Approach 1: Commodity Flow & Bottom Up Approach
1.4.2 Approach 2: Top Down and Parent Market Analysis

Chapter 2 Executive Summary
2.1 Market Snapshot

Chapter 3 Biotechnology Market: Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market Driver Analysis
3.1.1.1 Presence of favorable government initiatives
3.1.1.2 Rising demand for agro-based products
3.1.1.3 Growing demand for synthetic biology
3.1.1.4 Declining prices of DNA sequencing
3.1.1.5 Growing healthcare expenditure triggering development of effective PM diagnostic & therapeutic procedure for cancer
3.1.2 Market Restraint Analysis
3.1.2.1 Ethical issues related with clinical trials
3.1.2.2 Risks associated with GM organisms and crops
3.1.2.3 Challenges associated with NGS implementation
3.2 Penetration & Growth Prospect Mapping for Technology, 2016
3.3 Company market share analysis
3.4 Biotechnology Market - SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.5 Industry Analysis - Porter’s

Chapter 4 Biotechnology Market: Application Estimates & Trend Analysis
4.1 Biotechnology Market: Application Movement Analysis
4.2 Health
4.2.1 Global health biotechnology market, 2014 - 2025 (USD Billion)
4.3 Food & Agriculture
4.3.1 Global agriculture biotechnology market, 2014 - 2025 (USD Billion)
4.4 Natural resources & environment
4.4.1 Global natural resources & environment market, 2014 - 2025 (USD Billion)
4.5 Industrial Processing
4.5.1 Global industrial processing market, 2014 - 2025 (USD Billion)
4.6 Bioinformatics
4.6.1 Global bioinformatics market, 2014 - 2025 (USD Billion)
4.7 Other Applications
4.7.1 Global other applications market, 2014 - 2025 (USD Billion)

Chapter 5 Biotechnology Market: Technology Estimates & Trend Analysis
5.1 Biotechnology Market: Technology Movement Analysis
5.2 Nanobiotechnology
5.2.1 Global nanobiotechnology market, 2014 - 2025 (USD Billion)
5.3 Tissue engineering and regeneration
5.3.1 Global tissue engineering and regeneration market, 2014 - 2025 (USD Billion)
5.4 DNA Sequencing
5.4.1 Global DNA sequencing market, 2014 - 2025 (USD Billion)
5.5 Cell-based Assays
5.5.1 Global cell based assays market, 2014 - 2025 (USD Billion)
5.6 Fermentation
5.6.1 Global fermentation market, 2014 - 2025 (USD Billion)
5.7 PCR technology
5.7.1 Global PCR technology market, 2014 - 2025 (USD Billion)
5.8 Chromatography
5.8.1 Global chromatography instruments market, 2014 - 2025 (USD Billion)
5.9 Other Technologies
5.9.1 Global other technologies market, 2014 - 2025 (USD Billion)

Chapter 6 Biotechnology Market: Regional Estimates & Trend Analysis, by Application & Technology
6.1 Biotechnology Market Share by Region, 2016 & 2025
6.2 North America
6.2.1 North America biotechnology market, 2014 - 2025 (USD Billion)
6.2.2 U.S.
6.2.2.1 U.S. biotechnology market, by application, 2014 - 2025 (USD Billion)
6.2.2.2 U.S. biotechnology market, by technology, 2014 - 2025 (USD Billion)
6.2.3 Canada
6.2.3.1 Canada biotechnology market, by application, 2014 - 2025 (USD Billion)
6.2.3.2 Canada biotechnology market, by technology, 2014 - 2025 (USD Billion)
6.3 Europe
6.3.1 Europe biotechnology market, 2014 - 2025 (USD Billion)
6.3.2 Germany
6.3.2.1 Germany biotechnology market, by application, 2014 - 2025 (USD Billion)
6.3.2.2 Germany biotechnology market, by technology, 2014 - 2025 (USD Billion)
6.3.3 UK
6.3.3.1 UK biotechnology market, by application, 2014 - 2025 (USD Billion)
6.3.3.2 UK biotechnology market, by technology, 2014 - 2025 (USD Billion)
6.4 Asia Pacific
6.4.1 Asia Pacific biotechnology market, 2014 - 2025 (USD Billion)
6.4.2 Japan
6.4.2.1 Japan biotechnology market, by application, 2014 - 2025 (USD Billion)
6.4.2.2 Japan biotechnology market, by technology, 2014 - 2025 (USD Billion)
6.4.3 China
6.4.3.1 China biotechnology market, by application, 2014 - 2025 (USD Billion)
6.4.3.2 China biotechnology market, by technology, 2014 - 2025 (USD Billion)
6.5 Latin America
6.5.1 Latin America biotechnology market, 2014 - 2025 (USD Billion)
6.5.2 Brazil
6.5.2.1 Brazil biotechnology market, by application, 2014 - 2025 (USD Billion)
6.5.2.2 Brazil biotechnology market, by technology, 2014 - 2025 (USD Billion)
6.6 Middle East & Africa
6.6.1 Middle East & Africa biotechnology market, 2014 - 2025 (USD Billion)
6.6.2 South Africa
6.6.2.1 South Africa biotechnology market, by application, 2014 - 2025 (USD Billion)
6.6.2.2 South Africa biotechnology market, by technology, 2014 - 2025 (USD Billion)

Chapter 7 Competitive Landscape
7.1 Market participation categorization
7.2 Company Profiles
7.3 AstraZeneca
7.3.1 Company overview
7.3.2 Financial performance
7.3.3 Product benchmarking
7.3.4 Strategic initiatives
7.4 Gilead
7.4.1 Company overview
7.4.2 Financial performance
7.4.3 Product benchmarking
7.4.4 Strategic initiatives
7.5 CELGENE CORPORATION
7.5.1 Company overview
7.5.2 Financial performance
7.5.3 Product benchmarking
7.5.4 Strategic initiatives
7.6 Biogen
7.6.1 Company overview
7.6.2 Financial performance
7.6.3 Product benchmarking
7.6.4 Strategic initiatives
7.7 Abbott
7.7.1 Company overview
7.7.2 Financial performance
7.7.3 Product benchmarking
7.7.4 Strategic initiatives
7.8 Amgen, Inc.
7.8.1 Company overview
7.8.2 Financial performance
7.8.3 Product benchmarking
7.8.4 Strategic initiatives
7.9 Novo Nordisk A/S
7.9.1 Company overview
7.9.2 Financial performance
7.9.3 Product benchmarking
7.9.4 Strategic initiatives
7.10 Merck & Co
7.10.1 Company overview
7.10.2 Financial performance
7.10.3 Product benchmarking
7.10.4 Strategic initiatives
7.11 Johnson & Johnson Services, Inc.
7.11.1 Company overview
7.11.2 Financial performance
7.11.3 Product benchmarking
7.11.4 Strategic initiatives
7.12 Novartis AG
7.12.1 Company overview
7.12.2 Financial performance
7.12.3 Product benchmarking
7.12.4 Strategic initiatives
7.13 Sanofi Aventis
7.13.1 Company overview
7.13.1.1 Genzyme
7.13.2 Financial performance
7.13.3 Product benchmarking
7.13.4 Strategic initiatives
7.14 F. Hoffmann-La Roche Ltd
7.14.1 Company overview
7.14.2 Financial performance
7.14.3 Product benchmarking
7.14.4 Strategic initiatives
7.15 Pfizer, Inc.
7.15.1 Company overview
7.15.2 Financial performance
7.15.3 Product benchmarking
7.15.4 Strategic initiatives
7.16 Lonza
7.16.1 Company overview
7.16.2 Financial performance
7.16.3 Product benchmarking
7.16.4 Strategic initiatives

List of Tables
Table 1 Healthcare expenditure levels, 2012
Table 2 Various approaches in regenerative medicine for dermatological use
Table 3 North America: Clinical studies using HCT for hematopoietic and non-hematopoietic conditions (2016)
Table 4 North America biotechnology market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
Table 5 North America biotechnology market estimates & forecasts, by technology, 2014 - 2025 (USD Billion)
Table 6 U.S. biotechnology market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
Table 7 U.S. biotechnology market estimates & forecasts, by technology, 2014 - 2025 (USD Billion)
Table 8 Canada biotechnology market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
Table 9 Canada biotechnology market estimates & forecasts, by technology, 2014 - 2025 (USD Billion)
Table 10 Europe biotechnology market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
Table 11 Europe biotechnology market estimates & forecasts, by technology, 2014 - 2025 (USD Billion)
Table 12 Germany biotechnology market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
Table 13 Germany biotechnology market estimates & forecasts, by technology, 2014 - 2025 (USD Billion)
Table 14 UK biotechnology market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
Table 15 UK biotechnology market estimates & forecasts, by technology, 2014 - 2025 (USD Billion)
Table 16 Asia Pacific biotechnology market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
Table 17 Asia Pacific biotechnology market estimates & forecasts, by technology, 2014 - 2025 (USD Billion)
Table 18 Japan biotechnology market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
Table 19 Japan biotechnology market estimates & forecasts, by technology, 2014 - 2025 (USD Billion)
Table 20 Main monographs published in china
Table 21 China biotechnology market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
Table 22 China biotechnology market estimates & forecasts, by technology, 2014 - 2025 (USD Billion)
Table 23 Latin America: Current initiatives and opportunities
Table 24 Latin America biotechnology market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
Table 25 Latin America biotechnology market estimates & forecasts, by technology, 2014 - 2025 (USD Billion)
Table 26 Brazil biotechnology market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
Table 27 Brazil biotechnology market estimates & forecasts, by technology, 2014 - 2025 (USD Billion)
Table 28 MEA biotechnology market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
Table 29 MEA biotechnology market estimates & forecasts, by technology, 2014 - 2025 (USD Billion)
Table 30 South Africa biotechnology market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
Table 31 South Africa biotechnology market estimates & forecasts, by technology, 2014 - 2025 (USD Billion)

List of Figures
FIG. 1 Market research process
FIG. 2 Information Procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market snapshot
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Global area of biotech seeds, 2007 - 2012 (million acres)
FIG. 12 Revenues from GM and conventional seeds, 2007 - 2011 (USD Billion)
FIG. 13 Genome sequencing cost, 2002 - 2013 (USD thousands)
FIG. 14 Market restraint relevance analysis (Current & future impact)
FIG. 15 Region wise adverse clinical trials outcomes, 2013
FIG. 16 Penetration & growth prospect mapping for technology, 2016
FIG. 17 Company market share analysis, 2016
FIG. 18 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 19 Porter’s Five Forces Analysis
FIG. 20 Biotechnology market: Application outlook key takeaways
FIG. 21 Global biotechnology market: Application movement analysis
FIG. 22 Percentage of class-wise biopharmaceuticals offered by company
FIG. 23 Global health biotechnology market, 2014 - 2025 (USD Billion)
FIG. 24 Global food & agriculture biotechnology market, 2014 - 2025 (USD Billion)
FIG. 25 Global natural resources & environment market, 2014 - 2025 (USD Billion)
FIG. 26 Global industrial processing market, 2014 - 2025 (USD Billion)
FIG. 27 Global bioinformatics market, 2014 - 2025 (USD Billion)
FIG. 28 Global other applications market, 2014 - 2025 (USD Billion)
FIG. 29 Biotechnology market: Technology outlook key takeaways
FIG. 30 Biotechnology market: Technology movement analysis
FIG. 31 Breakdown of nanomedicine products in Phase III by therapeutic areas
FIG. 32 Global nanobiotechnology market, 2014 - 2025 (USD Billion)
FIG. 33 Global tissue engineering and regeneration market, 2014 - 2025 (USD Billion)
FIG. 34 Global DNA sequencing market, 2014 - 2025 (USD Billion)
FIG. 35 Global cell based assays market, 2014 - 2025 (USD Billion)
FIG. 36 Global fermentation market, 2014 - 2025 (USD Billion)
FIG. 37 Global PCR technology market, 2014 - 2025 (USD Billion)
FIG. 38 Global chromatography instruments market, 2014 - 2025 (USD Billion)
FIG. 39 Global other technologies market, 2014 - 2025 (USD Billion)
FIG. 40 Regional market place: Key takeaway
FIG. 41 Biotechnology regional outlook, 2016 & 2025
FIG. 42 North America biotechnology market, 2014 - 2025 (USD Billion)
FIG. 43 U.S. biotechnology market, 2014 - 2025 (USD Billion)
FIG. 44 Canada biotechnology market, 2014 - 2025 (USD Billion)
FIG. 45 Europe biotechnology market, 2014 - 2025 (USD Billion)
FIG. 46 Germany biotechnology market, 2014 - 2025 (USD Billion)
FIG. 47 UK biotechnology market, 2014 - 2025 (USD Billion)
FIG. 48 Asia Pacific biotechnology market, 2014 - 2025 (USD Billion)
FIG. 49 Japan biotechnology market, 2014 - 2025 (USD Billion)
FIG. 50 China biotechnology market, 2014 - 2025 (USD Billion)
FIG. 51 Latin America biotechnology market, 2014 - 2025 (USD Billion)
FIG. 52 Brazil biotechnology market, 2014 - 2025 (USD Billion)
FIG. 53 Middle East & Africa biotechnology market, 2014 - 2025 (USD Billion)
FIG. 54 South Africa biotechnology market, 2014 - 2025 (USD Billion)
FIG. 55 Participant categorization

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AstraZeneca
  • Gilead
  • CELGENE CORPORATION
  • Biogen
  • Abbott
  • Amgen, Inc.
  • Novo Nordisk A/S
  • Merck & Co
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • Sanofi Aventis
  • F. Hoffmann-La Roche Ltd
  • Pfizer, Inc.
  • Lonza
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll